Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction

被引:75
|
作者
Scheepens, WA
Jongen, MMGJ
Nieman, FHM
de Bie, RA
Weil, EHJ
van Kerrebroeck, PEV
机构
[1] Univ Hosp Maastricht, Dept Urol, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Clin Epidemiol, NL-6202 AZ Maastricht, Netherlands
[3] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
关键词
D O I
10.1016/S0090-4295(02)01841-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate data from 211 patients who underwent a trial stimulation (percutaneous nerve evaluation [PNE]) to determine the clinical parameters that can enhance the prediction of PNE success. The advantageous effect of sacral neuromodulation depends on the accurate identification of suitable candidates during the preimplantation PNE. Methods. A total of 211 patients (161 women and 50 men), with refractory urge incontinence, urgency-frequency syndrome, and urinary retention, underwent a PNE. Patient data (demographics, medical history, urologic investigations, and diagnosis) were collected. The PNE results were evaluated from a voiding diary and patient history. More than 50% improvement of voiding parameters was considered a successful PNE, and those patients were selected for implantation. Logistic regression analysis was performed. The factors tested for predicting the test result were sex, patient age, diagnosis, previous surgery, neurogenic bladder dysfunction, duration of complaints, and previous treatments. Results. The PNEs were positive in 85 patients (40.3%) and negative in 105 patients (49.8%). In 18 patients (8.5%), the test electrode had migrated; 3 more patients were not assessable and were also excluded. Missing data on the variable "duration of complaints" reduced the number of patients in the analyses from 190 to 174 patients. Conclusions. Intervertebral disk prolapse, duration of complaints, neurogenic bladder dysfunction, and urge incontinence were found to be significant predictive factors. However, a PNE remains necessary to evaluate a patient's chance of implant success objectively. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:598 / 602
页数:5
相关论文
共 50 条
  • [1] Sacral neuromodulation for lower urinary tract dysfunction
    Van Kerrebroeck, Philip E. V.
    Marcelissen, Tom A. T.
    [J]. WORLD JOURNAL OF UROLOGY, 2012, 30 (04) : 445 - 450
  • [2] Sacral neuromodulation for lower urinary tract dysfunction
    Philip E. V. Van Kerrebroeck
    Tom A. T. Marcelissen
    [J]. World Journal of Urology, 2012, 30 : 445 - 450
  • [3] Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction
    Hohenfellner, M
    Schultz-Lampel, D
    Dahms, S
    Matzel, K
    Thüroff, JW
    [J]. JOURNAL OF UROLOGY, 1998, 160 (03): : 821 - 824
  • [4] Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction
    J Wöllner
    J Krebs
    J Pannek
    [J]. Spinal Cord, 2016, 54 : 137 - 140
  • [5] Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction
    Pham, Cecile
    Parkin, Cameron
    Yeow, Siying
    Kovacic, James
    Yang, Yunzhi
    Delaney, Danielle
    Chung, Amanda
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 81 - 82
  • [6] Sacral neuromodulation and lower urinary tract dysfunction in cerebral palsy
    Ted M. Roth
    [J]. International Urogynecology Journal, 2007, 18 : 567 - 569
  • [7] Sacral neuromodulation and lower urinary tract dysfunction in cerebral palsy
    Roth, Ted M.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 (05) : 567 - 569
  • [8] Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction
    Woellner, J.
    Krebs, J.
    Pannek, J.
    [J]. SPINAL CORD, 2016, 54 (02) : 137 - 140
  • [9] Sacral neuromodulation for the management of neurogenic lower urinary tract dysfunction
    Albertsen, Peter
    [J]. BJU INTERNATIONAL, 2022, 130 (05) : 541 - 542
  • [10] Re: Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction
    Goldman, Howard B.
    [J]. EUROPEAN UROLOGY, 2023, 83 (02) : 184 - 184